Sonnet BioTherapeutics
SONN
SONN
1 hedge funds and large institutions have $474K invested in Sonnet BioTherapeutics in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$210K |
Top Sellers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$76K |
2 |
IC
Intersect Capital
San Ramon,
California
|
-$46K |
3 |
BlackRock
New York
|
-$40K |
4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$31K |
5 |
Bank of America
Charlotte,
North Carolina
|
-$20K |